Gulf Scientific Corporation (GSC), a leading provider of laboratory solutions in the Gulf Cooperation Council (GCC), has formed a strategic partnership with SOPHiA GENETICS, a global pioneer in data-driven medicine, headquartered in Switzerland.
GSC will now represent SOPHiA GENETICS across the UAE, Saudi Arabia, Oman, Qatar, and Bahrain, delivering their cutting-edge technologies to healthcare institutions across the region.
This partnership enhances GSC’s Life Science Portfolio, integrating SOPHiA GENETICS’ industry-leading solutions designed to advance precision medicine. SOPHiA GENETICS is recognized worldwide for leveraging artificial intelligence (AI) to provide multimodal analysis, enabling data-driven insights that transform the diagnosis and treatment of critical health conditions.
Through this collaboration, GSC will offer solutions to empower regional healthcare providers in tackling complex medical challenges, particularly in the areas of Oncology, Rare and Inherited Diseases, and Real-World Data. SOPHiA GENETICS’ multimodal analysis, powered by AI, combines data from multiple sources, providing actionable insights that enhance clinical decision-making, resulting in more personalized treatments and improved patient outcomes.
SOPHiA GENETICS’ solutions are widely used by healthcare professionals to support the research and monitoring of various cancers, facilitating the identification of specific mutations and biomarkers crucial for precision medicine planning.
SOPHiA GENETICS is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions.
